New York S01913 establishes the "340B prescription drug anti-discrimination act" to prevent discrimination against covered entities and New York.
New York S01913, the "340B prescription drug anti-discrimination act," aims to prohibit pharmaceutical manufacturers and pharmacy benefit managers from discriminating against covered entities and New York state pharmacies based on their participation in the federal drug discount program authorized by section 340B of the federal public health service act. The act bans practices such as limiting drug dispensing, denying access to drugs, or imposing different conditions on participating entities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.